[Effect of hydrocortisone in the control of nausea and vomiting during CAP therapy].
D015250:Aclarubicin; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D008875:Middle Aged; D009279:Naphthacenes / Q000009:adverse effects; D009325:Nausea / Q000188:drug therapy*; D017663:Peplomycin; D014839:Vomiting / Q000188:drug therapy*
D009279:Naphthacenes; D001761:Bleomycin; D017663:Peplomycin; D015250:Aclarubicin; D002945:Cisplatin; D006854:Hydrocortisone